New year, new you.
The country’s medical regulator has rejected an application to have MDMA and psilocybin legalised for clinical use, citing a lack of evidence.
The non-profit Freedom to Operate used research from chemists and crystallographers to argue in a legal filing that Compass’ form of synthetic psilocybin is not a new invention.
For the first time, researchers have been given ethics approval to study whether the psychedelic can be used to treat a primary anxiety disorder.
For-profit companies want psychedelics to be treated as medicine; others want them to just be legal. They'll have to learn to get along.
Canada and some U.S. jurisdictions are loosening their laws around psilocybin as black market dispensaries crop up.
Funded in part by Tim Ferriss, the Project on Psychedelics Law and Regulation will tackle the many unanswered legal questions facing psychedelic-assisted therapy.
A recent application from CB Therapeutics on biosynthetic psilocybin is emblematic of the IP concerns around novelty and obviousness the psychedelic field will face.
It found no significant difference in the psychological wellbeing of participants who took LSD or psilocybin mushrooms, and those who took a placebo capsule.
An attorney who specialises in psychedelic law tells us why we need to legalise psychedelics, how those caught with magic mushrooms have gotten away, and getting high for research.